Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study by Touroutoglou Nikolaos, Diamandidou Eleni, Agelaki Sofia, Kotsakis Athanasios, Vamvakas Lambros, Kalykaki Antonia, Christophylakis Charalambos, Kalbakis Kostas, Androulakis Nikolaos, Sfakiotaki Georgia, Emmanouilides Christos, Chatzidakis Adam, Georgoulias Vassilis, Mavroudis Dimitris, Souglakos John

Get full text